Receptor	receptor	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
nicotine-induced	nicotine-induced	O	O	O	O
locomotor	locomotor	O	DISEASE	OTHERS	I
hyperactivity	hyperactivity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
chronic	chronic	O	O	O	O
nicotine-treated	nicotine-treated	O	O	O	O
rats	rats	O	O	O	O
.	.	O	O	O	O

Rats	rats	O	O	O	O
were	were	O	O	O	O
pretreated	pretreated	O	O	O	O
with	with	O	O	O	O
saline	saline	O	O	O	O
or	or	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
1.5	1.5	O	O	O	O
mg/kg	mg/kg	O	O	O	O
per	per	O	O	O	O
day	day	O	O	O	O
)	)	O	O	O	O
by	by	O	O	O	O
subcutaneously	subcutaneously	O	O	O	O
implanting	implanting	O	O	O	O
each	each	O	O	O	O
animal	animal	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
Alzet	alzet	O	O	O	O
osmotic	osmotic	O	O	O	O
mini-pump	mini-pump	O	O	O	O
which	which	O	O	O	O
continuously	continuously	O	O	O	O
released	released	O	O	O	O
saline	saline	O	O	O	O
or	or	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
1	1	O	O	O	O
,	,	O	O	O	O
5	5	O	O	O	O
and	and	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
.	.	O	O	O	O

At	at	O	O	O	O
the	the	O	O	O	O
end	end	O	O	O	O
of	of	O	O	O	O
each	each	O	O	O	O
pretreatment	pretreatment	O	O	O	O
period	period	O	O	O	O
,	,	O	O	O	O
animals	animals	O	O	O	O
were	were	O	O	O	O
used	used	O	O	O	O
for	for	O	O	O	O
(	(	O	O	O	O
i	i	O	O	O	O
)	)	O	O	O	O
determining	determining	O	O	O	O
their	their	O	O	O	O
locomotor	locomotor	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
acutely	acutely	O	O	O	O
injected	injected	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
0.2	0.2	O	O	O	O
mg/kg	mg/kg	O	O	O	O
,	,	O	O	O	O
s.c	s.c	O	O	O	O
.	.	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
(	(	O	O	O	O
ii	ii	O	O	O	O
)	)	O	O	O	O
measuring	measuring	O	O	O	O
the	the	O	O	O	O
density	density	O	O	O	O
of	of	O	O	O	O
L-[3H]nicotine	l-[3h]nicotine	O	O	O	O
and	and	O	O	O	O
[3H]spiperone	[3h]spiperone	O	O	O	O
binding	binding	O	O	O	O
sites	sites	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
striatum	striatum	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
observed	observed	O	O	O	O
no	no	O	O	O	O
changes	changes	O	O	O	O
in	in	O	O	O	O
nicotine-induced	nicotine-induced	O	O	O	O
locomotor	locomotor	O	O	O	O
response	response	O	O	O	O
,	,	O	O	O	O
striatal	striatal	O	O	O	O
L-[3H]nicotine	l-[3h]nicotine	O	O	O	O
and	and	O	O	O	O
[3H]spiperone	[3h]spiperone	O	O	O	O
binding	binding	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
animals	animals	O	O	O	O
pretreated	pretreated	O	O	O	O
with	with	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
1	1	O	O	O	O
day	day	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
rats	rats	O	O	O	O
which	which	O	O	O	O
were	were	O	O	O	O
pretreated	pretreated	O	O	O	O
with	with	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
5	5	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
there	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
nicotine-stimulated	nicotine-stimulated	O	O	O	O
locomotor	locomotor	O	O	O	O
response	response	O	O	O	O
which	which	O	O	O	O
was	was	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
L-[3H]nicotine	l-[3h]nicotine	O	O	O	O
binding	binding	O	O	O	O
sites	sites	O	O	O	O
and	and	O	O	O	O
also	also	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
elevated	elevated	O	O	O	O
dopamine	dopamine	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
DA	da	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
level	level	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
striatum	striatum	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
striatal	striatal	O	O	O	O
[3H]spiperone	[3h]spiperone	O	O	O	O
binding	binding	O	O	O	O
sites	sites	O	O	O	O
was	was	O	O	O	O
not	not	O	O	O	O
affected	affected	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
animals	animals	O	O	O	O
pretreated	pretreated	O	O	O	O
with	with	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
14	14	O	O	O	O
days	days	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
nicotine-induced	nicotine-induced	O	O	O	O
locomotor	locomotor	O	O	O	O
response	response	O	O	O	O
remained	remained	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
potentiated	potentiated	O	O	O	O
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
this	this	O	O	O	O
response	response	O	O	O	O
was	was	O	O	O	O
correlated	correlated	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
elevated	elevated	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
striatal	striatal	O	O	O	O
[3H]spiperone	[3h]spiperone	O	O	O	O
binding	binding	O	O	O	O
sites	sites	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
the	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
striatal	striatal	O	O	O	O
L-[3H]nicotine	l-[3h]nicotine	O	O	O	O
binding	binding	O	O	O	O
sites	sites	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
striatal	striatal	O	O	O	O
DA	da	CHEMICALS	O	OTHERS	I
level	level	O	O	O	O
were	were	O	O	O	O
normal	normal	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
chronic	chronic	O	O	O	O
nicotine-treated	nicotine-treated	O	O	O	O
rats	rats	O	O	O	O
develop	develop	O	O	O	O
locomotor	locomotor	O	DISEASE	OTHERS	I
hyperactivity	hyperactivity	O	DISEASE	OTHERS	I
in	in	O	O	O	O
response	response	O	O	O	O
to	to	O	O	O	O
nicotine	nicotine	CHEMICALS	O	OTHERS	I
initially	initially	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
increases	increases	O	O	O	O
of	of	O	O	O	O
both	both	O	O	O	O
the	the	O	O	O	O
density	density	O	O	O	O
of	of	O	O	O	O
nicotinic	nicotinic	O	O	O	O
receptors	receptors	O	O	O	O
and	and	O	O	O	O
DA	da	CHEMICALS	O	OTHERS	I
concentration	concentration	O	O	O	O
,	,	O	O	O	O
followed	followed	O	O	O	O
by	by	O	O	O	O
inducing	inducing	O	O	O	O
DA	da	CHEMICALS	O	OTHERS	I
receptor	receptor	O	O	O	O
supersensitivity	supersensitivity	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
striatum	striatum	O	O	O	O
.	.	O	O	O	O

